摘要
自2019年12月起,2019冠状病毒病(COVID-19,又称新型冠状病毒肺炎)首先在武汉被发现,随后该病迅速蔓延至全国乃至其他国家。该病具有传播广、死亡及重症率高的特点,影响深远,引起国内外的广泛重视。而脑血管病同样为我国人群主要的慢性疾病,每年也可造成一定的死亡及致残风险。COVID-19的发病机制与脑血管病的危险因素以及脑血管病本身都有很密切的关系,易合并存在,引发院内感染。笔者根据COVID-19现有的资料结合以往相关疾病的临床经验对新型冠状病毒与脑血管疾病的关系做一归纳,以求更好地指导临床个体化诊疗。
Coronavirus disease 2019(COVID-19)was first discovered in Wuhan.Since December 2019,this disease,with the characteristics of a wide epidemic,high mortality,and high probability of deterioration,has spread rapidly throughout our country and even all over the world,which has a far-reaching impact and has attracted widespread attention at home and abroad.Cerebrovascular disease is also a primary chronic disease in the Chinese population,causing a certain risk of death and disability every year.The pathogenesis of COVID-19 is closely related to the risk factors of cerebrovascular disease and itself,which is prone to coexist and cause nosocomial infection.The author summarizes the relationship between severe acute respiratory syndrome coronavirus 2 and cerebrovascular disease based on the existing data of COVID-19 and the clinical experience of related diseases to better guide clinical individualized diagnosis and treatment.
作者
王族
宋海庆
Wang Zu;Song Haiqing(Department of Neurology,Xuanwu Hospital,Capital Medical University,Beijing 100053,China)
出处
《中国脑血管病杂志》
CAS
CSCD
北大核心
2020年第3期163-168,共6页
Chinese Journal of Cerebrovascular Diseases
基金
国家重点研发计划重大慢性非传染性疾病防控研究重点专项(2016YFC1300600)
国家自然科学基金(81801142)。
关键词
2019冠状病毒病
新型冠状病毒
脑血管病
高血压
药物治疗
综述
Coronavirus disease 2019
Severe acute respiratory syndrome coronavirus 2
Cerebrovascular disease
Hypertension
Medication
Review
